Consumer Driven Testing - Help or Hindrance

11.30am – 12pm BST, 28 September 2023 ‐ 30 mins

Room: Hall 11B

The Association of Clinical Biochemistry & Laboratory Medicine

Abstract

Direct to Consumer Testing (DTCT) has been expanding across the UK in recent years. This is partly due new technology becoming available, private sector appetite for profit and increasing demand from patients to take more control of their own health and fill the gap left by an increasingly rationed NHS. There are however significant issues associated with such expansion. A relative lack of regulation of products becoming available flags up potential quality issues - especially for at home point of care testing kits purchased over the internet. Test appropriateness is also questionable, with large panels of tests (2-300) being offered in some instances, which inevitably will flag up many false positive results.

The lack of interoperability with NHS databases and method differences will inevitably mean such DTCT results will not be comparable or incorporable into NHS patient records. Patients turning up to GP practices with pages of test results will impose an additional burden on the NHS at a time when it is already under huge pressure. Policy and guidance on regulation, quality, appropriateness and incorporation into patient records will be needed to ensure patient care is optimised.